Evaluation of the Predictive Value of 18F-fluorodeoxyglucose Positron Emission Tomography and Brain Perfusion Computed Tomography for the Efficacy of Anti-angiogenic Therapy (Bevacizumab) in Recurrent Glioblastoma
Condition: Glioblastoma Interventions: Other: FDG PET; Other: CT scan; Other: Magnetic resonance imaging (MRI) Sponsor: Centre Hospitalier Universitaire de Nīmes Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials